ITU Unit Action

TALTZ

Eli Lilly and Company

ITU Unit Action

Trademark Snap Shot ITU Unit Action (Table presents the data on ITU Unit Action)
OVERVIEW
SERIAL NUMBER	85476614	FILING DATE	11/18/2011
REG NUMBER	0000000	REG DATE	N/A
REGISTER	PRINCIPAL	MARK TYPE	TRADEMARK
INTL REG #	N/A	INTL REG DATE	N/A
TM ATTORNEY	MACIOL, GENE V J	L.O. ASSIGNED	103

PUB INFORMATION
RUN DATE	07/02/2015
PUB DATE	11/20/2012
STATUS	734-FIFTH EXTENSION - GRANTED
STATUS DATE	07/01/2015
LITERAL MARK ELEMENT	TALTZ

DATE ABANDONED	N/A	DATE CANCELLED	N/A
SECTION 2F	NO	SECTION 2F IN PART	NO
SECTION 8	NO	SECTION 8 IN PART	NO
SECTION 15	NO	REPUB 12C	N/A
RENEWAL FILED	NO	RENEWAL DATE	N/A
DATE AMEND REG	N/A

FILING BASIS
FILED BASIS		CURRENT BASIS		AMENDED BASIS
1 (a)	NO	1 (a)	NO	1 (a)	NO
1 (b)	YES	1 (b)	YES	1 (b)	NO
44D	NO	44D	NO	44D	NO
44E	NO	44E	NO	44E	NO
66A	NO	66A	NO
NO BASIS	NO	NO BASIS	NO

MARK DATA
STANDARD CHARACTER MARK	YES
LITERAL MARK ELEMENT	TALTZ
MARK DRAWING CODE	4-STANDARD CHARACTER MARK
COLOR DRAWING FLAG	NO

CURRENT OWNER INFORMATION
PARTY TYPE	20-OWNER AT PUBLICATION
NAME	Eli Lilly and Company
ADDRESS	Lilly Corporate Center Indianapolis, IN 46285
ENTITY	03-CORPORATION
CITIZENSHIP	Indiana

GOODS AND SERVICES
INTERNATIONAL CLASS	005
DESCRIPTION TEXT	Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, pancreatic diseases and disorders, psychiatric disorders, reproductive system diseases and disorders, sleep disorders, urological disorders; antipsychotic pharmaceutical preparations; antidepressants

GOODS AND SERVICES CLASSIFICATION
INTERNATIONAL CLASS	005	FIRST USE DATE	NONE	FIRST USE IN COMMERCE DATE	NONE	CLASS STATUS	6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS
CHANGE IN REGISTRATION	NO

PROSECUTION HISTORY
DATE	ENT CD	ENT TYPE	DESCRIPTION	ENT NUM
07/02/2015	EXRA	E	NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	037
07/01/2015	EX5G	S	EXTENSION 5 GRANTED	036
06/29/2015	EXT5	S	EXTENSION 5 FILED	035
06/29/2015	EEXT	I	TEAS EXTENSION RECEIVED	034
01/16/2015	EXRA	E	NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	033
01/15/2015	EX4G	S	EXTENSION 4 GRANTED	032
01/14/2015	EXT4	S	EXTENSION 4 FILED	031
01/14/2015	EEXT	I	TEAS EXTENSION RECEIVED	030
06/12/2014	EXRA	E	NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	029
06/11/2014	EX3G	S	EXTENSION 3 GRANTED	028
06/10/2014	EXT3	S	EXTENSION 3 FILED	027
06/10/2014	EEXT	I	TEAS EXTENSION RECEIVED	026
12/20/2013	EXRA	E	NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	025
12/19/2013	EX2G	S	EXTENSION 2 GRANTED	024
12/17/2013	EXT2	S	EXTENSION 2 FILED	023
12/17/2013	EEXT	I	TEAS EXTENSION RECEIVED	022
08/06/2013	EXRA	E	NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	021
08/05/2013	EX1G	S	EXTENSION 1 GRANTED	020
07/10/2013	EXT1	S	EXTENSION 1 FILED	019
08/03/2013	AITU	A	CASE ASSIGNED TO INTENT TO USE PARALEGAL	018
07/10/2013	EEXT	I	TEAS EXTENSION RECEIVED	017
01/15/2013	NOAM	E	NOA E-MAILED - SOU REQUIRED FROM APPLICANT	016
11/20/2012	NPUB	E	OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	015
11/20/2012	PUBO	A	PUBLISHED FOR OPPOSITION	014
10/31/2012	NONP	E	NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	013
10/15/2012	PREV	O	LAW OFFICE PUBLICATION REVIEW COMPLETED	012
10/15/2012	ALIE	A	ASSIGNED TO LIE	011
10/01/2012	CNSA	P	APPROVED FOR PUB - PRINCIPAL REGISTER	010
08/31/2012	TEME	I	TEAS/EMAIL CORRESPONDENCE ENTERED	009
08/31/2012	CRFA	I	CORRESPONDENCE RECEIVED IN LAW OFFICE	008
08/31/2012	TROA	I	TEAS RESPONSE TO OFFICE ACTION RECEIVED	007
03/15/2012	GPRN	O	NOTIFICATION OF PRIORITY ACTION E-MAILED	006
03/15/2012	GPRA	F	PRIORITY ACTION E-MAILED	005
03/15/2012	CPRA	R	PRIORITY ACTION WRITTEN	004
03/06/2012	DOCK	D	ASSIGNED TO EXAMINER	003
11/28/2011	NWOS	I	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	002
11/22/2011	NWAP	I	NEW APPLICATION ENTERED IN TRAM	001

CURRENT CORRESPONDENCE INFORMATION
ATTORNEY	Robert E. Lee, Jr.
CORRESPONDENCE ADDRESS	ROBERT E. LEE, JR. ELI LILLY AND COMPANY LILLY CORPORATE CENTER INDIANAPOLIS, IN 46285-0001
DOMESTIC REPRESENTATIVE	NONE

PRIOR OWNER INFORMATION
PARTY TYPE	10-ORIGINAL APPLICANT
NAME	Eli Lilly and Company
ADDRESS	Lilly Corporate Center Indianapolis, IN 46285
ENTITY	03-CORPORATION
CITIZENSHIP	Indiana

ITU Unit Action [image/jpeg]

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.